α-lipoic acid modulates extracellular matrix and angiogenesis gene expression in non-healing wounds treated with hyperbaric oxygen therapy

被引:26
作者
Alleva, Renata [1 ]
Tomasetti, Marco [2 ]
Sartini, Davide [3 ]
Emanuelli, Monica [3 ]
Nasole, Emanuele [4 ]
Di Donato, Ferruccio [4 ]
Borghi, Battista [1 ]
Santarelli, Lory [2 ]
Neuzil, Jiri [5 ,6 ]
机构
[1] IRCCS Ist Orthoped Rizzoli, Dept Anesthesiol, I-40136 Bologna, Italy
[2] Polytech Univ Marche, Dept Mol Pathol & Innovat Therapies, Ancona, Italy
[3] Polytech Univ Marche, Inst Biochem Biotechnol, Ancona, Italy
[4] MPM, Hyperbar Ctr, Bologna, Italy
[5] Griffith Univ, Apoptosis Res Grp, Sch Med Sci, Southport, Qld, Australia
[6] Acad Sci Czech Republ, Inst Mol Genet, Mol Therapy Grp, Prague, Czech Republic
关键词
D O I
10.2119/2007-00095.Alleva
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
alpha-Lipoic acid (LA) has been found previously to accelerate wound repair in patients affected by chronic wounds who underwent hyperbaric oxygen (HBO) therapy. Because proteinases are important in wound repair, we hypothesized that LA may regulate matrix metalloproteinase (MMP) expression in cells that are involved in wound repair. Patients undergoing HBO therapy were double-blind randomized into two groups: the LA group and the placebo group. Gene expression profiles for MMPs and for angiogenesis mediators were evaluated in biopsies collected at the first HBO session, at the seventh HBO session, and after 14 days of HBO treatment. ELISA tests were used to validate microarray expression of selected genes. LA supplementation in combination with HBO therapy downregulated the inflammatory cytokines and the growth factors which, in turn, affect MMPs expression. The disruption of the positive autocrine feedback loops that maintain the chronic wound state promotes progression of the healing process.
引用
收藏
页码:175 / 183
页数:9
相关论文
共 45 条
[1]
The role of hyperbaric oxygen therapy in ischaemic diabetic lower extremity ulcers: a double-blind randomised-controlled trial [J].
Abidia, A ;
Laden, G ;
Kuhan, G ;
Johnson, BF ;
Wilkinson, AR ;
Renwick, PM ;
Masson, EA ;
McCollum, PT .
EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2003, 25 (06) :513-518
[2]
α-Lipoic acid supplementation inhibits oxidative damage, accelerating chronic wound healing in patients undergoing hyperbaric oxygen therapy [J].
Alleva, R ;
Nasole, E ;
Di Donato, F ;
Borghi, B ;
Neuzil, J ;
Tomasetti, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 333 (02) :404-410
[3]
AMSTRONG DG, 2002, J AM PODIAT MED, V92, P12
[4]
R-(+)-α-lipoic acid inhibits endothelial cell apoptosis and proliferation:: involvement of Akt and retinoblastoma protein/E2F-1 [J].
Artwohl, Michaela ;
Muth, Kathrin ;
Kosulin, Karin ;
De Martin, Rainer ;
Lzenbein, Thomas Ho ;
Rainer, Georg ;
Freudenthaler, Angelika ;
Huttary, Nicole ;
Schmetterer, Leopold ;
Usl, Werner K. Waldha ;
Baumgartner-Parzer, Sabina M. .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2007, 293 (03) :E681-E689
[5]
Hyperbaric oxygen induces basic fibroblast growth factor and hepatocyte growth factor expression, and enhances blood perfusion and muscle regeneration in mouse ischemic hind limbs [J].
Asano, Tetsuichi ;
Kaneko, Eiji ;
Shinozaki, Shohei ;
Imai, Yutaka ;
Shibayama, Masaharu ;
Chiba, Tsuyoshi ;
Ai, Masumi ;
Kawakami, Akio ;
Asaoka, Hiroshi ;
Nakayama, Toru ;
Mano, Yoshihiro ;
Shimokado, Kentaro .
CIRCULATION JOURNAL, 2007, 71 (03) :405-411
[6]
AWAILI NS, 2006, SCI WORLD J, V6, P425
[7]
Proteinases, their inhibitors, and cytokine profiles in acute wound fluid [J].
Baker, EA ;
Leaper, DJ .
WOUND REPAIR AND REGENERATION, 2000, 8 (05) :392-398
[8]
Is hyperbaric oxygen a useful adjunct in the management of problem lower extremity wounds? [J].
Ciaravino, ME ;
Friedell, ML ;
Kammerlocher, TC .
ANNALS OF VASCULAR SURGERY, 1996, 10 (06) :558-562
[9]
Adenoviral-mediated gene transfer in wound healing [J].
Crombleholme, TM .
WOUND REPAIR AND REGENERATION, 2000, 8 (06) :460-472
[10]
KERATINOCYTE-DERIVED VASCULAR-PERMEABILITY FACTOR (VASCULAR ENDOTHELIAL GROWTH-FACTOR) IS A POTENT MITOGEN FOR DERMAL MICROVASCULAR ENDOTHELIAL-CELLS [J].
DETMAR, M ;
YEO, KT ;
NAGY, JA ;
VANDEWATER, L ;
BROWN, LF ;
BERSE, B ;
ELICKER, BM ;
LEDBETTER, S ;
DVORAK, HF .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1995, 105 (01) :44-50